A nurse is collecting data from a client who has been taking carbamazepine. Which of the following is an adverse effect of carbamazepine and should be reported to the provider?

A. Increased respiratory rate is a sign that naloxone is effectively reversing opioid-induced respiratory depression. Opioids can suppress the respiratory drive, leading to hypoventilation or respiratory arrest. Naloxone works by competitively binding to opioid receptors and displacing opioids, thereby restoring normal respiratory function.
B. Increased temperature is not a direct effect of naloxone administration. Naloxone primarily reverses the central nervous system depressant effects of opioids, including respiratory depression and sedation, rather than affecting body temperature.
C. Naloxone does not directly affect pain perception. Its primary action is to reverse the respiratory depression and central nervous system depression caused by opioids. While the client may experience pain relief indirectly as a result of improved respiratory function and consciousness, naloxone itself does not directly reduce pain.
D. Decreased blood pressure is not a direct effect of naloxone administration. Naloxone primarily reverses the respiratory and central nervous system depressant effects of opioids, rather than affecting blood pressure directly.

A. According to the recommended immunization schedule, the second dose of the MMR vaccine is typically administered at 4 to 6 years of age, before starting school. This booster dose helps ensure long- term immunity against measles, mumps, and rubella.
B. The MMR vaccine is typically administered in two doses: the first dose at 12 to 15 months of age and the second dose at 4 to 6 years of age. There is no need for additional MMR immunizations over the next 2 years if the child receives the recommended doses.
C. While the child may receive additional immunizations at 3 years of age, such as the hepatitis B vaccine, the second dose of the MMR vaccine is typically administered at 4 to 6 years of age, not 3 years.
D. Titer testing is typically not recommended for determining the need for further MMR immunizations in young children. The immunization schedule provides specific recommendations for MMR vaccine doses based on age, rather than individual titers.